Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| ciliated cell | 11 studies | 36% ± 13% | |
| GABAergic neuron | 6 studies | 33% ± 16% | |
| glutamatergic neuron | 5 studies | 28% ± 13% | |
| neuron | 3 studies | 26% ± 5% | |
| retinal ganglion cell | 3 studies | 46% ± 21% | |
| interneuron | 3 studies | 23% ± 3% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 6 studies | 23% ± 11% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| prostate | 78% | 768.18 | 190 / 245 | 99% | 249.50 | 496 / 502 |
| brain | 95% | 3646.99 | 2520 / 2642 | 71% | 34.52 | 499 / 705 |
| lung | 89% | 1027.99 | 512 / 578 | 56% | 65.75 | 642 / 1155 |
| adrenal gland | 38% | 227.00 | 98 / 258 | 78% | 83.92 | 179 / 230 |
| spleen | 100% | 2528.67 | 241 / 241 | 0% | 0 | 0 / 0 |
| pancreas | 8% | 37.09 | 25 / 328 | 81% | 109.99 | 145 / 178 |
| stomach | 67% | 351.82 | 241 / 359 | 20% | 11.77 | 58 / 286 |
| heart | 86% | 2923.85 | 737 / 861 | 0% | 0 | 0 / 0 |
| thymus | 16% | 71.02 | 102 / 653 | 60% | 19.78 | 366 / 605 |
| eye | 0% | 0 | 0 / 0 | 66% | 15.42 | 53 / 80 |
| esophagus | 49% | 394.13 | 706 / 1445 | 16% | 5.15 | 30 / 183 |
| intestine | 29% | 116.99 | 276 / 966 | 20% | 9.34 | 104 / 527 |
| ovary | 2% | 9.67 | 3 / 180 | 40% | 23.46 | 172 / 430 |
| skin | 8% | 33.16 | 147 / 1809 | 31% | 10.61 | 144 / 472 |
| uterus | 11% | 79.71 | 18 / 170 | 25% | 12.82 | 116 / 459 |
| kidney | 10% | 42.00 | 9 / 89 | 22% | 20.76 | 201 / 901 |
| liver | 10% | 42.42 | 23 / 226 | 17% | 6.24 | 70 / 406 |
| tonsil | 0% | 0 | 0 / 0 | 27% | 10.25 | 12 / 45 |
| breast | 1% | 9.20 | 5 / 459 | 24% | 8.63 | 267 / 1118 |
| bladder | 0% | 0 | 0 / 21 | 21% | 15.72 | 104 / 504 |
| lymph node | 0% | 0 | 0 / 0 | 10% | 2.05 | 3 / 29 |
| muscle | 4% | 26.06 | 35 / 803 | 0% | 0 | 0 / 0 |
| adipose | 1% | 3.51 | 10 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 1% | 5.00 | 11 / 1335 | 0% | 0 | 0 / 0 |
| peripheral blood | 0% | 1.27 | 1 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0043524 | Biological process | negative regulation of neuron apoptotic process |
| GO_0005576 | Cellular component | extracellular region |
| GO_0016020 | Cellular component | membrane |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0005515 | Molecular function | protein binding |
| Gene name | VSTM2L |
| Protein name | V-set and transmembrane domain-containing protein 2-like protein |
| Synonyms | C20orf102 |
| Description | |
| Accessions | ENST00000373461.9 [Q96N03-1] ENST00000373459.4 [Q96N03-3] ENST00000448944.1 [Q96N03-2] Q96N03 |